This company has shut down. PredictImmune is no longer operating.
Explore the Startup GraveyardProviding tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
PredictImmune's investors include Parkwalk Advisors, Business Growth Fund, Wellcome Trust, Cambridge Innovation Capital, Innovate UK.
PredictImmune is headquartered in Cambridge, United Kingdom.
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
PredictImmune is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PredictImmune — Funding & Investors." VCBacked, March 20, 2023, https://www.vcbacked.co/company/predictimmune. Accessed August 16, 2026.
VCBacked. (2023). PredictImmune — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/predictimmune
{{cite web |title=PredictImmune — Funding & Investors |url=https://www.vcbacked.co/company/predictimmune |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated